INVESTOR RELATIONS

Investor Presentation

Who we are

Ortho RTI is an emerging Orthobiologics company dedicated to the development of novel therapeutic tissue repair technologies to dramatically improve the success rate of orthopedic and sports medicine surgeries.

Our Technology

Our proprietary technology platform, is a muco-adhesive CHITOSAN based biopolymer matrix, specifically designed to deliver biologics such as Platelet-Rich Plasma (PRP) or Bone Marrow Aspirate Concentrate (BMAC), to augment and guide the regeneration of new tissue in various musculoskeletal conditions.

Product pipeline

Ortho-R, our lead Chitosan-PRP hybrid biologic implant combination product, is formulated and designed to increase the healing rates of occupational and sports related injuries to tendons, meniscus and ligaments. Other formulations are being developed for cartilage repair, bone void filling and osteoarthritis treatment.

Value proposition :